recombin
adenoassoci
viral
raav
vector
exhibit
interest
properti
vaccin
carrier
abil
induc
longlast
antibodi
respons
howev
raavbas
vaccin
suggest
trigger
function
impair
longterm
memori
cell
respons
part
due
poor
dendrit
cell
dc
transduct
result
albeit
limit
intramuscular
immun
undermin
use
raav
vaccin
vehicl
intracellular
pathogen
report
intraderm
immun
model
vaccin
drive
develop
bona
fide
longterm
memori
cell
respons
intraderm
rout
immun
presenc
potent
major
histocompat
complex
mhc
class
ii
respons
show
synergist
effect
overal
quantiti
qualiti
system
longterm
effector
memori
transgenespecif
cell
gener
transgen
key
interest
found
induct
memori
cytotox
lymphocyt
ctl
follow
intraderm
immun
sole
depend
crosspresent
skinexpress
transgen
product
appear
highli
enhanc
compar
muscleexpress
transgen
product
overal
result
highlight
key
tissuespecif
differ
transgen
present
pathway
requir
import
design
raavbas
cellinduc
vaccin
sinc
initi
report
show
recombin
vector
deriv
singlestrand
dna
parvoviru
adenoassoci
viru
raav
could
gener
adapt
immun
respons
encod
transgen
raav
progress
drawn
interest
potenti
vaccin
vehicl
raav
lead
high
level
transgen
express
target
tissu
devoid
encod
viral
gene
well
toler
clinic
trial
far
numer
serotyp
capsid
variant
character
allow
heterolog
primeboost
regimen
well
broad
tissu
tropism
particular
interest
induct
local
immun
experi
conduct
variou
anim
model
confirm
abil
raav
drive
sustain
protect
humor
immun
varieti
inject
rout
howev
report
function
impair
memori
cell
respons
induc
follow
intramuscular
immun
led
current
paradigm
raav
vector
poorli
suit
induct
cellular
immun
key
requir
protect
immun
intracellular
pathogen
subcellular
local
transgen
product
presenc
major
histocompat
complex
mhc
class
ii
epitop
vector
dose
capsid
serotyp
rout
immun
target
tissu
inflammatori
statu
shown
influenc
gener
adapt
immun
follow
raav
inject
key
limit
raav
vector
gener
potent
cytotox
cell
cytotox
lymphocyt
ctl
respons
encod
transgen
notabl
resid
limit
trigger
local
inflamm
poor
transduct
antigenpres
cell
achiev
common
raav
serotyp
latter
probabl
impos
enhanc
relianc
effici
crosspresent
tissueexpress
transgen
product
dendrit
cell
dc
effici
cell
prime
follow
raavmedi
vaccin
muscl
harbor
macrophag
dc
steadi
state
skin
hous
extens
network
resid
dc
repres
wellcharacter
tissu
vaccin
deliveri
effici
crosspresent
capac
defin
subset
skin
dc
report
importantli
experiment
data
obtain
context
vaccinia
viru
immun
suggest
direct
present
pathway
dispens
context
intraderm
intramuscular
immun
spite
clear
interest
potenti
raavbas
vaccin
scarc
data
exist
regard
adapt
immun
respons
induc
follow
raav
intraderm
immun
knowledg
one
report
focus
antitransgen
humor
respons
use
model
vector
report
studi
synergi
cell
help
target
skin
vector
express
model
ovalbumin
transgen
lead
increas
number
qualiti
main
antitransgen
memori
cell
subset
importantli
process
appear
sole
reli
enhanc
crosspresent
skinexpress
transgen
product
elimin
need
addit
strategi
aim
enhanc
raavmedi
dc
transduct
investig
impact
skin
target
gener
memori
cell
respons
context
raavbas
vaccin
made
use
vector
encod
fulllength
membranebound
form
ovalbumin
model
antigen
fuse
uti
dbi
male
hy
antigen
epitop
figur
previous
describ
context
intramuscular
immun
construct
induc
strong
ova
specif
cell
dbi
specif
cell
respons
femal
mice
male
mice
natur
toler
male
antigen
dbi
specif
cell
respons
absent
ova
specif
cell
respons
curtail
strongli
depend
transgen
express
hematopoiet
cell
import
male
mice
respond
similarli
femal
mice
set
mhc
class
iirestrict
ova
epitop
lead
detect
cell
respons
first
test
whether
ova
dbi
specif
cell
respons
could
obtain
follow
intraderm
immun
two
week
immun
ear
clear
dbi
specif
respons
could
observ
spleen
femal
male
mice
figur
mean
sem
n
mice
per
group
pool
least
three
independ
experi
p
p
twoway
anovasidak
test
femal
mice
immun
ear
dermi
id
vg
movahi
inject
ear
collect
day
immun
ear
section
stain
red
antimhc
class
ii
blue
antibodi
left
imag
show
zproject
maximum
intens
origin
mosaic
imag
acquir
leica
confoc
microscop
use
oil
pl
apo
object
right
imag
show
enlarg
region
interest
depict
top
right
corner
left
imag
imag
analysi
perform
use
imagej
softwar
ova
specif
cell
respons
could
observ
blood
figur
spleen
data
shown
intraderm
immun
femal
mice
level
similar
intramuscularli
immun
mice
cell
infiltr
could
observ
dermi
epidermi
inject
ear
figur
male
mice
absenc
cell
help
ova
specif
cell
respons
reduc
figur
previous
seen
follow
intramuscular
immun
figur
result
thu
highlight
skin
suitabl
target
organ
vaccin
vaccin
extend
previou
observ
skelet
muscl
regard
impact
cell
help
primari
cell
respons
induc
vector
rout
immun
cell
help
synerg
regul
induct
bona
fide
memori
cell
follow
immun
character
impact
rout
immun
format
memori
cell
follow
raavmedi
immun
next
analyz
phenotyp
memori
cell
gener
follow
singl
prime
model
raavbas
vaccin
day
intramuscular
immun
absenc
help
mostli
induc
low
number
splenic
ovaspecif
ova
termin
differenti
effector
hi
eff
effector
memori
hi
em
cell
well
popul
drain
lymph
noderesid
ova
em
figur
importantli
compar
control
vector
signific
popul
central
memori
hi
cm
cell
could
detect
lymphoid
organ
intramuscularli
immun
mice
overal
frequenc
ovaspecif
memori
cell
gener
appear
greatli
impact
cell
help
rout
administr
line
observ
peak
effector
cell
respons
figur
howev
context
intramuscular
immun
simpli
ad
cell
help
femal
intramuscular
versu
male
intramuscular
lead
increas
gener
central
memori
cm
effector
memori
em
cell
figur
cell
help
inde
mostli
induc
splenic
effector
cell
figur
signific
increas
ova
cm
em
spleen
drain
lymph
node
sole
observ
follow
intraderm
immun
presenc
cell
help
femal
intraderm
figur
result
suggest
key
role
skinderiv
cue
synergi
cell
help
regul
longterm
memori
cell
differenti
reexpress
receptor
involv
receiv
surviv
signal
environ
key
step
longterm
memori
cell
gener
natur
express
naiv
cell
downregul
upon
activ
reexpress
upon
memori
differenti
prototyp
exampl
receptor
context
intramuscular
immun
absenc
help
weakli
reexpress
antitransgen
longliv
effector
effector
memori
popul
gener
figur
simpli
switch
intramuscular
intraderm
rout
immun
suffici
restor
reexpress
splenic
ova
em
figur
level
even
higher
naiv
cell
partial
reexpress
splenic
eff
data
shown
cell
help
alon
littl
impact
interestingli
ova
cm
popul
uniqu
gener
follow
intraderm
immun
presenc
cell
help
bore
even
higher
level
figur
anoth
key
properti
memori
cell
predict
marker
protect
immun
capac
rapidli
perform
multipl
effector
function
includ
product
variou
effector
cytokin
intramuscular
immun
absenc
cell
help
led
ovaspecif
cell
mostli
capabl
produc
interferon
ifn
g
less
capabl
produc
tumor
necrosi
factor
alpha
tnfa
respect
figur
cell
help
skin
target
independ
enhanc
overal
polyfunction
gener
memori
cell
spleen
figur
intraderm
immun
howev
highest
impact
product
figur
well
uniqu
impact
differenti
polyfunct
memori
ctl
drain
lymph
node
figur
overal
result
demonstr
key
synergi
cell
help
rout
administr
control
full
acquisit
bona
fide
central
effectormemori
phenotyp
antitransgen
cell
follow
raav
immun
result
line
absenc
detect
longterm
express
transgen
skin
muscl
previous
describ
immun
femal
mice
figur
besid
transgen
intrins
factor
encod
mhc
class
ii
epitop
abil
given
raav
serotyp
effici
transduc
dc
vivo
thu
lead
effici
direct
present
transgen
product
brought
forward
key
limit
factor
raav
vector
induc
potent
ctl
respons
underli
evid
paradigm
howev
mostli
deriv
intramuscular
intraperiton
immun
might
fulli
reflect
known
differ
peripher
tissu
dc
network
potenti
crosspres
exogen
antigen
thu
next
investig
requir
transgen
express
dc
induct
cell
respons
upon
vector
administr
skin
address
question
made
use
construct
figur
microrna
natur
express
cell
hematopoiet
lineag
adjunct
target
sequenc
transgen
shown
lead
robust
suppress
transgen
express
wwwmoleculartherapyorg
hematopoiet
cell
includ
dc
popul
upon
lentivir
transduct
similar
result
obtain
use
transduct
b
express
murin
dc
cell
line
figur
similar
transduct
effici
vector
figur
note
line
previou
report
human
dc
singlestrand
raav
construct
appear
poorli
express
dc
led
limit
direct
transgen
pre
figur
rout
immun
cell
help
synerg
regul
gener
effector
memori
cell
antiova
memori
cell
respons
analyz
day
day
postimmun
spleen
drain
lymph
node
dln
male
femal
mice
immun
tibiali
anterior
im
ear
dermi
id
vg
movahi
see
also
figur
mice
immun
control
vector
rel
express
repres
ratio
indic
cell
popul
medianfi
medianfi
endogen
naiv
cell
popul
individu
account
potenti
interexperiment
variat
stain
mice
signific
level
ova
memori
subset
interest
mean
sd
control
vector
includ
analysi
mean
sem
ae
n
mice
per
group
pool
least
three
independ
experi
ns
nonsignific
p
p
p
p
ad
twoway
anovasidak
test
e
repeatedmeasur
rm
oneway
anovasidak
test
sentat
vitro
cell
line
even
highest
moi
figur
previous
shown
intramuscular
immun
construct
absenc
dbi
specif
respons
lead
reduc
cell
respons
figur
contrast
similar
cell
respons
observ
construct
follow
intraderm
immun
male
mice
mild
reduct
intens
respons
day
result
suggest
direct
prime
dc
dispens
induct
strong
cell
respons
follow
skin
target
vector
context
intramuscular
immun
howev
effici
crossprim
transgenespecif
ctl
tissueexpress
transgen
product
seen
presenc
concomit
dbi
specif
helper
cell
respons
figur
importantli
also
observ
potent
gener
memori
subset
follow
immun
construct
appear
follow
rule
seen
wildtyp
movahi
construct
maxim
induct
effectormemori
mice
signific
level
ova
memori
cell
spleen
mean
sd
control
vector
includ
analysi
n
mice
per
group
pool
least
three
independ
experi
analysi
present
distribut
perform
use
spice
version
background
unstimul
correct
data
pairwis
comparison
distribut
insid
panel
perform
use
student
test
partial
permut
test
describ
signific
p
differ
display
p
p
subset
notabl
ova
cm
achiev
combin
skin
target
strong
cell
help
figur
reach
frequenc
indistinguish
gener
wildtyp
movahi
construct
effector
memori
subset
similar
trend
observ
analyz
express
ova
em
cm
figur
overal
polyfunction
gener
antitransgen
memori
ctl
figur
note
howev
intramuscular
immun
cell
help
alon
insuffici
restor
maxim
ctl
polyfunction
transgen
figur
unlik
wildtyp
movahi
construct
target
skin
prove
indispens
context
test
whether
memori
ctl
respons
gener
sole
crosspresent
skinexpress
transgen
product
confer
protect
advantag
context
secondari
pathogen
encount
challeng
mice
intraperiton
ip
lethal
dose
colonyform
unit
cfu
ovaexpress
recombin
listeria
monocytogen
lmova
protect
immun
model
pathogen
shown
reli
mostli
lmspecif
ctl
femal
mice
previous
immun
control
vector
gradual
lost
weight
day
postinfect
figur
time
point
mice
analyz
harbor
cfu
lmova
spleen
line
known
kinet
pathogenesi
associ
lm
infect
contrast
intraderm
crossprim
induc
singl
immun
suffici
achiev
clear
protect
weight
loss
curtail
day
figur
complet
clearanc
bacteri
load
day
analyz
femal
mice
infect
also
control
male
mice
figur
intraderm
intramuscular
weight
loss
curtail
day
incomplet
bacteri
clearanc
could
observ
intramuscularli
immun
male
mice
time
point
observ
line
quantit
qualit
enhanc
effectormemori
cell
respons
observ
presenc
cell
help
figur
result
obtain
model
system
construct
suggest
key
differ
regard
relianc
ctl
respons
effici
transgen
express
dc
muscl
skin
two
tissu
routin
target
vaccin
differ
crossprim
could
result
either
enhanc
tissueexpress
transgen
crosspresent
local
environment
cue
enhanc
cell
prime
next
aim
directli
monitor
crosspresent
event
vivo
mice
immun
via
intramuscular
rout
robust
activ
transfer
naiv
ovaspecif
cell
receptor
tcr
transgen
cell
detect
day
restrict
muscledrain
lymph
node
figur
surprisingli
clear
transgen
express
could
detect
time
point
dc
subpopul
sort
inject
tibiali
anterior
muscl
drain
lymph
node
figur
figur
despit
clear
express
inject
tibiali
anterior
muscl
low
express
equival
level
seen
cell
context
moi
figur
could
detect
migratori
dc
harvest
ear
drain
lymph
node
two
three
experi
follow
intraderm
immun
figur
ova
present
howev
reproduc
observ
lymphoid
dc
migratori
dc
follow
intramuscular
intraderm
immun
vector
figur
notabl
strong
present
eardrain
lymph
node
migratori
dc
line
restrict
transgen
express
nonhematopoiet
tissu
ova
transgen
appear
sole
present
migratori
dc
skin
muscledrain
lymph
node
present
latter
mostli
restrict
subset
figur
migratori
dc
subset
account
less
dc
skin
muscledrain
lymph
node
time
point
figur
went
back
vivo
assess
physiolog
consequ
restrict
transgen
express
nonhematopoiet
lineag
addit
target
sequenc
construct
led
reduc
delay
present
ova
follow
intramuscular
immun
figur
line
observ
reduct
dc
present
primari
cell
respons
figur
cell
help
limit
impact
present
transgen
figur
interestingli
robust
activ
transfer
alreadi
detect
day
follow
intraderm
immun
movahi
construct
level
continu
higher
intramuscular
control
group
day
figur
could
simpli
reflect
quantit
effect
rather
qualit
differ
respect
contribut
crosspresent
pathway
follow
skin
deliveri
analyz
ova
present
follow
intraderm
immun
use
lower
dose
wildtyp
movahi
construct
contrast
strike
differ
ova
present
observ
day
construct
follow
immun
muscl
highest
dose
figur
mhc
class
present
skintarget
ova
transgen
equal
effect
dose
studi
figur
overal
result
confirm
mark
depend
crosspresent
overal
mhc
class
present
raav
transgen
detect
direct
present
major
dc
subset
experiment
set
suggest
dual
sourc
tissu
hematopoiet
cell
deriv
transgen
crosspresent
skin
dc
exhibit
enhanc
potenti
crosspresent
tissueexpress
neoantigen
limit
crosspresent
efficaci
muscleexpress
antigen
impos
enhanc
relianc
addit
cue
immun
system
cell
help
induc
potent
crossprim
ctl
respons
b
c
rel
express
live
splenic
ova
em
indic
individu
b
live
splenic
ova
eff
dark
gray
ova
em
light
gray
ova
cm
white
id
immun
femal
mice
c
describ
figur
product
ifng
tnfa
measur
ova
peptid
mgml
vitro
restimul
splenic
cell
suspens
rel
proport
singl
white
doubl
light
gray
tripl
dark
gray
cytokineproduc
ova
stimul
live
cell
isol
spleen
dln
display
describ
figur
mean
sem
ad
n
mice
per
group
pool
least
three
independ
experi
ns
nonsignific
p
p
p
p
b
twoway
anovasidak
test
c
rm
oneway
anovasidak
test
studi
made
use
uniqu
model
transgen
address
three
potenti
requir
optim
raavinduc
cell
memori
cell
help
direct
express
transgen
antigenpres
cell
optim
immun
rout
result
first
exemplifi
previous
unappreci
synergi
cell
help
skin
target
regul
optim
differenti
antitransgen
ctl
memori
outmost
interest
raav
vaccin
result
demonstr
strong
requir
transgen
crosspresent
context
raav
immun
highlight
transgen
express
hematopoiet
cell
import
sourc
antigen
crosspresent
context
intramuscular
intraderm
immun
first
key
find
studi
target
skin
compar
skelet
muscl
result
signific
increas
frequenc
system
antigenspecif
high
em
high
cm
cell
correl
increas
frequenc
antigenspecif
tnfa
ifng
tripl
produc
key
cytokin
secondari
prolifer
memori
cell
absenc
potent
produc
among
raavinduc
memori
ctl
follow
intramuscular
immun
correl
reduc
respons
secondari
boost
impact
rout
administr
prime
antitransgen
ctl
report
studi
line
previou
report
perform
context
gene
therapi
vaccin
vector
name
compar
intramuscular
immun
subcutan
immun
shown
induc
stronger
ctl
respons
intranas
immun
shown
induc
enhanc
frequenc
antitransgen
cell
respons
precis
phenotyp
memori
ctl
gener
fulli
examin
studi
would
like
suggest
result
obtain
skin
regard
qualiti
memori
cell
respons
appli
rout
immun
intranas
rout
interest
question
rais
studi
exact
natur
mechan
drive
longterm
memori
cell
differenti
follow
intraderm
immun
number
mechan
consid
far
explain
limit
induct
potent
effectormemori
ctl
follow
intramuscular
immun
raav
vector
includ
raavintrins
poor
dc
transduct
abil
insuffici
inflammatori
respons
lead
poor
mhc
class
upregul
myocyt
sustain
transgen
express
transgeneintrins
limit
lack
potent
mhc
class
ii
epitop
construct
result
suggest
combin
signal
might
need
cell
help
inde
requir
gener
bona
fide
memori
ctl
follow
intraderm
immun
vector
line
key
impact
ctl
crossprim
via
dc
licens
product
cell
help
howev
promot
enhanc
differenti
termin
differenti
effector
cell
context
intramuscular
immun
previous
shown
context
immun
respons
sever
pathogen
interestingli
target
skin
result
enhanc
transgen
express
dc
time
first
wave
antigen
present
drain
lymph
node
although
rule
earlier
express
lead
multipl
distinct
celldc
interact
moreov
induct
potent
antitransgen
memori
cell
respons
follow
intraderm
immun
appear
independ
transgen
express
hematopoiet
cell
final
target
skin
inde
associ
better
longterm
clearanc
transgen
howev
whether
loss
transgen
express
preced
result
enhanc
differenti
ctl
still
unknown
differ
environment
cue
dc
subset
among
numer
mechan
alreadi
propos
regul
effectormemori
cell
fate
start
hypothesi
skin
natur
harbor
larg
divers
dc
popul
direct
contact
commens
flora
would
less
depend
skelet
muscl
vectorintrins
inflammatori
properti
recruit
activ
memori
cell
crosspresent
pathway
combin
first
time
vivo
ex
vivo
analysi
transgen
present
dc
restrict
transgen
express
nonhematopoiet
cell
data
highlight
key
differ
skelet
muscl
skin
antitransgen
cell
prime
context
intramuscular
immun
found
present
hematopoiet
cellexpress
transgen
lymph
noderesid
dc
essenti
drive
potent
cell
respons
follow
intraderm
immun
lymphoid
dc
well
migratori
dc
similarli
present
hematopoiet
cellexpress
transgen
product
howev
complet
loss
present
event
led
reduct
peak
primari
cell
respons
sole
crosspresent
skinexpress
transgen
suffici
maxim
induct
memori
ctl
respons
point
previou
studi
highlight
potenc
crosspresent
vivo
induct
primari
ctl
respons
vaccinia
viru
modifi
vaccinia
viru
ankara
lentiviru
vector
result
illustr
key
impact
cellular
sourc
antigen
effici
crosspresent
event
complement
previou
studi
field
enhanc
crosspresent
cellassoci
antigen
follow
local
intraderm
rather
system
intraven
deliveri
describ
context
membranebound
ova
model
antigen
result
suggest
might
repres
uniqu
properti
skin
share
peripher
tissu
includ
skelet
muscl
potenc
skinexpress
transgen
crosspresent
suggest
effici
induct
memori
ctl
respons
sole
depend
abil
given
vector
drive
antigen
express
nonhematopoiet
skin
cell
extend
beyond
initi
scope
studi
understand
whether
hold
true
context
raav
serotyp
well
inject
techniqu
design
better
target
variou
layer
skin
microneedl
patch
skin
surfac
strip
transcutan
vaccin
via
laser
micropor
could
prove
key
interest
overal
studi
highlight
skin
potenti
interest
target
site
futur
raavbas
vaccin
ad
dosespar
potenti
intraderm
immun
believ
result
prompt
global
assess
potenti
individu
raav
serotyp
induc
strong
cellmedi
immun
respons
protect
memori
follow
intraderm
vaccin
donor
oti
mice
carri
tcr
specif
ova
bound
b
bred
anim
facil
movahyexpress
construct
recombin
vector
prepar
previous
describ
briefli
mova
cdna
fuse
dbi
uti
epitop
encod
sequenc
encompass
respect
five
ntermin
ctermin
amino
acid
four
ntermin
four
ctermin
amino
acid
origin
protein
sequenc
ensur
normal
process
construct
insert
plasmid
hpgk
promot
polya
signal
creat
construct
construct
four
repeat
target
sequenc
addit
insert
utr
plasmid
control
vector
use
throughout
studi
vector
code
cre
recombinas
lymphoid
organcel
suspens
prepar
immun
recipi
mechan
dissoci
spleen
pool
poplit
inguin
muscledrain
lymph
node
pool
superfici
cervic
parotid
mandibular
eardrain
lymph
node
steril
pb
contain
human
serum
albumin
hsa
cell
per
organ
directli
stain
restimul
hr
vitro
ml
complet
rpmi
medium
contain
mgml
brefeldin
sigmaaldrich
mgml
ova
peptid
siinfekl
proteogenix
cell
suspens
prepar
mechan
dispers
pool
spleen
inguin
axillari
cervic
mesenter
lymph
node
donor
oti
mice
steril
pb
contain
hsa
cell
suspens
stain
pb
contain
mgml
violet
prolifer
dye
vpd
bd
bioscienc
min
c
follow
two
wash
pb
contain
hsa
hsa
respect
vpdlabel
cell
inject
retroorbit
venou
sinu
previous
immun
mice
final
volum
ml
pb
dc
sort
drain
lymph
node
inject
tissu
three
mice
pool
experi
drain
lymph
nodecel
suspens
prepar
incub
min
c
pb
contain
mgml
collagenas
roch
mm
cacl
mgml
dnasei
sigmaaldrich
enrich
cell
use
function
grade
purifi
manufactur
instruct
subsequ
stain
perform
ebiosci
permeabil
buffer
ebiosci
min
c
use
combin
pe
antitnfa
apc
antiifng
data
collect
facscanto
ii
lsrii
fortessa
flow
cytomet
analyz
use
flowjo
softwar
tree
star
antibodi
purchas
biolegend
unless
state
otherwis
mice
challeng
ip
cfu
recombin
strain
listeria
monocytogen
express
ova
erythromycin
resist
marker
day
challeng
spleen
homogen
lyse
nacl
bacteri
titer
assess
plate
dilut
brainheart
infus
agar
supplement
mgml
erythromycin
grown
day
c
lowest
dilut
use
dilut
origin
solut
give
us
limit
detect
cfusspleen
total
rna
isol
use
nucleospin
rna
purif
kit
machereynagel
accord
manufactur
instruct
submit
extra
dnase
treatment
step
use
turbo
dnafre
kit
life
technolog
quantif
ova
mrna
total
rna
revers
transcrib
use
random
primer
superscript
ii
revers
transcriptas
life
technolog
ml
cdna
subject
realtim
pcr
amplif
use
ovaf
ovar
gaa
bactinf
aagatctggcac
bactinr
ttttcacggttggcct
primer
reaction
mixtur
ml
quantifast
sybr
green
mastermix
life
technolog
use
final
volum
ml
ova
primer
nm
bactin
primer
nm
quantif
rel
amount
ova
mrna
sampl
done
use
ddct
method
normal
bactin
mrna
use
common
refer
experi
cdna
gener
pool
tibiali
anterior
mice
data
shown
mean
sem
statist
analys
perform
use
graphpad
prism
softwar
version
indic
nonparametr
wilcoxon
test
two
group
kruskalwallisdunn
test
repeatedmeasur
rm
oneway
anova
three
group
twoway
anova
follow
sidak
posttest
analysi
two
variabl
cell
help
rout
immun
perform
select
pairwis
comparison
minim
level
confid
result
consid
signific
p
p
p
p
p
supplement
inform
includ
five
figur
found
articl
onlin
http
